Alison Calver

5.6k total citations · 1 hit paper
39 papers, 4.4k citations indexed

About

Alison Calver is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Alison Calver has authored 39 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 14 papers in Physiology and 11 papers in Surgery. Recurrent topics in Alison Calver's work include Nitric Oxide and Endothelin Effects (14 papers), Coronary Interventions and Diagnostics (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alison Calver is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Coronary Interventions and Diagnostics (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Alison Calver collaborates with scholars based in United Kingdom and United States. Alison Calver's co-authors include Joe Collier, Patrick Vallance, A. Leone, Salvador Moncada, Patrick Vallance, Anna Leone, Brian F. Robinson, David J. Webb, Nigel Benjamin and Nick Curzen and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Hypertension.

In The Last Decade

Alison Calver

37 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1992 1.8k citations A. Leone, Patrick Vallance et al. The Lancet profile →

Peers

Countries citing papers authored by Alison Calver

Since Specialization

Citations

This map shows the geographic impact of Alison Calver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Calver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Calver more than expected).

Fields of papers citing papers by Alison Calver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Calver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Calver. The network helps show where Alison Calver may publish in the future.

Co-authorship network of co-authors of Alison Calver

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Calver. A scholar is included among the top collaborators of Alison Calver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Calver. Alison Calver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Association between troponin level and medium-term mortality in 20 000 hospital patients	Heart	Jonathan Hinton, Zoe Nicholas et al.	6
2	The effect of COVID-19 on training in cardiology: a survey of UK cardiology trainees	European Heart Journal	Andrew R. Chapman, Thomas Gilpin et al.	1
3	Relation of High-Sensitivity Troponin to 1 Year Mortality in 20,000 Consecutive Hospital Patients Undergoing a Blood Test for Any Reason	The American Journal of Cardiology	Jonathan Hinton, Zoe Nicholas et al.	1
4	True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study	BMJ	Jonathan Hinton, Zoe Nicholas et al.	39
5	Women in Cardiology	European Heart Journal	Abhishek Joshi, Christopher Allen et al.	18
6	Lesson of the month 1: Beware the atypical presentation: eosinophilic granulomatosis with polyangiitis presenting as acute coronary syndrome	Clinical Medicine	Bashir Alaour, Alison Calver et al.	7
7	Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?	Journal of Thrombosis and Haemostasis	Nalyaka Sambu, Borislav D. Dimitrov et al.	8
8	Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?	Circulation Cardiovascular Interventions	Nick Curzen, Omer Rana et al.	151
9	Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry	Heart	Nalyaka Sambu, Alison Calver et al.	53
10	Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study	Heart	Nalyaka Sambu, Nicola A. Englyst et al.	30
11	Stent thrombosis and antiplatelet therapy: a review of 3004 consecutive patients in a single centre	ePrints Soton (University of Southampton)	Nick Curzen, Geraint Morton et al.	2
12	Uterine artery embolisation for massive uterine fibroids in the presence of submassive pulmonary emboli	BJOG An International Journal of Obstetrics & Gynaecology	Christopher J. Boos, Alison Calver et al.	4
13	Combined Percutaneous Management of an Atrial Septal Defect and Coronary Artery Disease	Journal of Interventional Cardiology	Alison Calver, Keith D. Dawkins et al.	2
14	Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents	American Heart Journal	Alison Calver, Keith D. Dawkins et al.	32
15	Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.	Journal of Pharmacology and Experimental Therapeutics	RJ MacAllister, Alison Calver et al.	51
16	Role of nitric oxide in cardiovascular control in healthy subjects and in patients with renal failure.	PubMed	Alison Calver, Joe Collier et al.	1
17	Nitric oxide and cardiovascular control	Experimental Physiology	Alison Calver, Joe Collier et al.	139
18	Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure breakdown →	The Lancet	A. Leone, Patrick Vallance et al.	1759
19	Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis	Journal of Cardiovascular Pharmacology	Patrick Vallance, Anna Leone et al.	388
20	Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.	Journal of Clinical Investigation	Alison Calver, Joe Collier et al.	445

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact